Tempus PRO™

Get the complete picture for mental health treatment response

 

Tempus PRO™ is a digital tool that automatically combines patient response to evidence-based screening assessments, with objective insights from patient lifestyle data. You can now easily and accurately measure patient treatment response over time to deliver better mental health care.¹

 

Patient lifestyle data and feedback on medication response are critical inputs for mental health treatment.¹ But, maintaining touch-points and documentation with your patient in between appointments is hard.

 

Tempus PRO™ is a digital tool that automatically combines patient response to evidence-based screening assessments, with objective insights from patient lifestyle data. You can now easily track your patient’s response to your selected treatment in between appointments

Objective insights from patient lifestyle data

 

• View summarized data such as sleep quality, mood and daily steps to get a holistic view of patient response to your selected treatment.

 

• Ability to integrate with your patient’s smartphone fitness tracker.

Library of over 90 digital assessments

 

• Evidence based assessments such as the Frequency Intensity Burden of Side Effects Rating (FIBSER) to monitor adverse drug reaction, Vanderbilt Scale for ADHD, ACE Questionnaire for PTSD and more.

 

• Assessments for depression, anxiety, ADHD and other conditions.

 

• Automatically assign and score digital screeners and worksheets.

Patient friendly interface

 

• Assessments and worksheets can be completed within a few minutes

 

• Reminders for your patient to check-in and log any side effects, progress and overall well-being

Summarized results tracked over time

 

• Visualize assessment response to quickly identify if your patient is responding to treatment

A recent real-world data analysis showed Tempus PRO™ used in combination with pharmacogenomic (PGx) testing is associated with a significant decrease in symptom severity (-9%, matched pairs t-test p=1e-10).

 

Additionally, patients who received PGx testing showed higher engagement and retention with Tempus PRO™, with an average of 8.9 assessments completed over a retention period of 80 days.¹

1. Preliminary Results of Symptom Tracking using Tempus PROTM of Patients with PGx Testing From a Real-World Clinical Dataset Poster. Psych Congress 2022 September 17-20, 2022 New Orleans.

 

Note: Tempus PRO™ is for patients who are age 13 and older.